Videos
Could Hepatitis C Become a Rare Disease?
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug Sovaldi, discusses implications of curative HCV drugs on the long term outcome for patients worldwide.
Hepatitis C Patient Journey: A Miracle Cure for HCV
In part five, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how his hepatitis C was cured through a clinical trial.
What's Next in the Hepatitis C Drug Pipeline
Janice Wahl, MD, Executive Director of Infectious Diseases at Merck Research Laboratories, discusses the latest developments in hepatitis C treatment at Merck.
What Hepatitis C Patients Need to Know When Starting Sovaldi Regimen
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug Sovaldi, discusses what patients can expect when they begin a therapeutic regimen with the drug.
$auto_registration$